FFAR2 and graft versus host disease: Furthermore, there was no difference in GVHD severity when BMT hosts were transplanted with allogeneic T cells from either WT or Gpr43−/− B6 donors demonstrating that GPR43 expression on donor T cells does not contribute to GVHD severity (Fig. 4k, l).